Utility of quantitative MRI metrics for assessment of stage and grade of urothelial carcinoma of the bladder: Preliminary results

American Journal of Roentgenology

Volumn 201, Issue 6, 2013, Pages 1254-1259

  Rosenkrantz, Andrew B ^a   Haghighi, Mohammad ^a   Horn, Jeremy ^b   Naik, Mohit ^a   Hardie, Andrew D ^a   Somberg, Molly B ^a   Melamed, Jonathan ^a   Xiao, Guang Qian ^b   Huang, William C ^a   Taouli, Bachir ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Apparent diffusion coefficient; BLADDER cancer; Diffusion weighted imaging; MRI; T2 weighted imaging

Indexed keywords

AGED; AREA UNDER THE CURVE; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CYSTECTOMY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; MEASUREMENT ACCURACY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 84888391860     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.12.10348     Document Type: Article

References (17)

1. American Cancer Society website. Selected cancers: urinary bladder. In: Cancer facts and figures, 2012. www.cancer.org/acs/groups/content/ @epidemiologysurveilance/documents/document/acspc-031941.pdf Published 2012. Accessed July 31, 2013.
2. Hall MG, Chang SS, Dalagni G, et al. Bladder cancer guideline for the management of nonmuscle invasive bladder cancer: (stages Ta, T1, and Tis): 2007 update. J Urol 2007; 178:2314-2330.
3. Hollingsworth JM, Zhang Y, Krein SL, Ye Z, Hollenbeck BK. Understanding the variation in treatment intensity among patients with early stage bladder cancer. Cancer 2010; 116:3587-3594.
4. Hollenbeck BK, Ye Z, Dunn RL, Montie JE, Birkmeyer JD. Provider treatment intensity and outcomes for patients with early-stage bladder cancer. J Natl Cancer Inst 2009; 101:571-580.
5. Kobayashi S, Koga F, Yoshida S, et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol 2011; 21:2178-2186.
6. Takeuchi M, Sasaki S, Ito M, et al. Urinary bladder cancer: diffusion-weighted MR imaging-accuracy for diagnosing T stage and estimating histologic grade. Radiology 2009; 251:112-121.
7. Fujimoto H, Tobisu K, Teshima S, Kishi K, Kakizoe T. Tumor recurrence and grade and/or stage progression in low grade tumor: Analysis of 154 patients with superficial transitional cell carcinoma of the bladder [in Japanese]. Nippon Hinyokika Gakkai Zasshi 1993; 84:1013-1018.
8. Allard P, Bernard P, Fradet Y, Tetu B. The early clinical course of primary Ta and T1 bladder cancer: A proposed prognostic index. Br J Urol 1998; 81:692-698.
9. Simone G, Papalia R, Loreto A, Leonardo C, Sentinelli S, Gallucci M. Independent prognostic value of tumour diameter and tumour necrosis in upper urinary tract urothelial carcinoma. BJU Int 2009; 103:1052-1057.
10. Radbruch A, Lutz K, Wiestler B, et al. Relevance of T2 signal changes in the assessment of progression of glioblastoma according to the Response Assessment in Neurooncology criteria. Neuro Oncol 2012; 14:222-229.
11. Wang L, Mazaheri Y, Zhang J, Ishill NM, Kuroiwa K, Hricak H. Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. Radiology 2008; 246:168-176.
12. El-Assmy A, Abou-El-Ghar ME, Mosbah A, et al. Bladder tumour staging: comparison of diffusionand T2-weighted MR imaging. Eur Radiol 2009; 19:1575-1581.
13. Montironi R, Lopez-Beltran A. The 2004 WHO classification of bladder tumors: A summary and commentary. Int J Surg Pathol 2005; 13:143-153.
14. Zelhof B, Pickles M, Liney G, et al. Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer. BJU Int 2009; 103:883-888.
15. Squillaci E, Manenti G, Cova M, et al. Correlation of diffusion-weighted MR imaging with cellularity of renal tumours. Anticancer Res 2004; 24:4175- 4179.
16. Hatakenaka M, Soeda H, Yabuuchi H, et al. Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci 2008; 7:23-29.
17. Guo AC, Cummings TJ, Dash RC, Provenzale JM. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002; 224:177-183.